StreetInsider.com News Articles

Form 8-K Glucotrack, Inc. For: Aug 28

Fri, 28 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260828/26999067.html

Form 8-K Glucotrack, Inc. For: Aug 28

Fri, 28 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260828/26999067.html

Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc.

Fri, 28 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260828/26998556.html

Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc.

Fri, 28 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260828/26998556.html

Form 8-K/A Glucotrack, Inc. For: Jul 09

Fri, 28 Aug 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260828/26998452.html

Form 8-K/A Glucotrack, Inc. For: Jul 09

Fri, 28 Aug 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260828/26998452.html

Form 8-K Glucotrack, Inc. For: Aug 27

Thu, 27 Aug 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260827/26985632.html

Form 8-K Glucotrack, Inc. For: Aug 27

Thu, 27 Aug 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260827/26985632.html

Glucotrack announces 1-for-15 reverse stock split effective Aug. 31

Thu, 27 Aug 2026 08:01:51 -0400

Glucotrack, Inc. (Nasdaq: GCTK) announced a 1-for-15 reverse stock split of its issued and outstanding common stock, effective at the opening of trading on August 31, 2026.

The split will reduce the total number of outstanding shares from 11,972,157 to approximately 798,144. Stockholder ownership percentages will remain unchanged, except for adjustments related to fractional shares. No fractional shares will be issued; instead, shareholders holding a number of shares not evenly divisible by 15 will receive an additional fraction to round up to the next whole share.

The company's common stock will continue to trade on the Nasdaq Capital Market under the ticker

Glucotrack announces 1-for-15 reverse stock split effective Aug. 31

Thu, 27 Aug 2026 08:01:51 -0400

Glucotrack, Inc. (Nasdaq: GCTK) announced a 1-for-15 reverse stock split of its issued and outstanding common stock, effective at the opening of trading on August 31, 2026.

The company's common stock will continue to trade on the Nasdaq Capital Market under the ticker

Glucotrack, Inc. Announces Reverse Stock Split

Thu, 27 Aug 2026 08:00:00 -0400

1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a healthcare technology and biopharmaceutical company operating Lōkahi Therapeutics™, today announced that it will effect a 1-for-15 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock par value $0.001 per share (the “Common Stock”), effective with the opening of trading on Monday, August 31, 2026.

Glucotrack’s Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol

Glucotrack, Inc. Announces Reverse Stock Split

Thu, 27 Aug 2026 08:00:00 -0400

1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026

Glucotrack’s Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol

Glucotrack, Inc. Announces Reverse Stock Split

Thu, 27 Aug 2026 08:00:00 -0400

1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026

Glucotrack’s Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol

Glucotrack, Inc. Announces Reverse Stock Split

Thu, 27 Aug 2026 08:00:00 -0400

1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026

Glucotrack’s Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol

Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100